Copart (CPRT) Q4 2026 earnings review
U.S. core stalls and margins compress, overwhelming international growth
Copart grew revenue just 2.4% to $1,152.4 million, carried entirely by an 11.7% expansion in the international segment while the U.S. core stagnated at 0.4%. With top-line growth unable to cover rising yard costs, gross margin compressed by 3.5 points. Net income fell 17.4%, though a 4.7% reduction in the share count buffered the EPS decline to 14.6%.
The print strengthens the bear case by breaking the company's price-offset narrative. Facility operations consumed an additional 1.9 points of revenue, proving that without volume growth or substantial pricing power, the fixed-cost base deleverages severely. Furthermore, the capital rotation from cash to buybacks removed the interest-income cushion, dropping other income by 45.6% and exposing the operating weakness.
What remains open is the depth of the U.S. volume contraction. The release omitted the operational metrics needed to test the claims-cycle thesis; the upcoming 10-K will settle whether the domestic decline remains cyclical or if structural share loss has permanently impaired the primary engine.
⚖️ Verdict: 🔴 Bearish
🐂 Bull Case
International as the Growth Engine
The international segment remains the clear bright spot, growing revenue 11.7% to $222.1 million and single-handedly preventing a consolidated top-line contraction. However, the segment's operating leverage has softened: operating income grew a more modest 3.0%, indicating that while international volume is expanding, it is not generating the same margin profile the domestic business historically enjoyed.
Capital Return Cushions the Per-Share Line
By redirecting capital away from land acquisitions and toward the share count over the past year, management effectively shielded the per-share metrics from the full severity of the earnings decline. Diluted shares outstanding fell 4.7% year-over-year to 932.1 million, which converted a 17.4% drop in net income into a 14.6% decline in EPS. The rotation prioritizes the balance sheet over physical capacity at the bottom of the cycle.
Standing positives the print did not read on
Two standing drivers got no reading in this release, as the company did not provide the supplemental business details typically shared on earnings calls.
- Whole-car TAM sizing: no dollar or unit figure was disclosed for the non-insurance channel.
- Buyer-base diversification: no geographic mix update was provided to test resilience across trade corridors.
🐻 Bear Case
Margin Compression Replaces the Price Offset
Management's standing narrative is that pricing power offsets volume headwinds, but this quarter broke that mechanism entirely. Gross margin compressed by 3.5 points to 41.8%, driven directly by facility operations consuming an additional 1.9 points of revenue and the cost of vehicle sales taking another 1.1 points. Without unit growth or substantial pricing power, the fixed-cost base deleveraged severely.
If the upcoming 10-K shows the U.S. insurance ASP growth offset has faded entirely, the consolidated margin contraction will persist until volumes recover.
The U.S. Core Stalls
The domestic business stalled outright, growing revenue just 0.4% to $930.3 million. That stagnation cascaded violently down the P&L, leading to a 12.7% decline in U.S. operating income. The domestic insurance volume decline, flagged as moderating last quarter, appears to have weighed heavily on the segment's profitability, proving that the 81%-of-revenue primary engine cannot currently cover its own yard costs.
Earnings Quality Deteriorates Below the Per-Share Line
Net income fell 17.4% year-over-year, dropping significantly faster than the 10.6% decline in operating income. The gap came from below the operating line: total other income dropped 45.6% to $35.8 million, primarily because interest income contracted by 20.5%. Draining the cash balance for buybacks removed the interest-income cushion that had previously flattered the company's earnings profile.
Standing risks the print did not read on
Five standing concerns got no reading in this release, as the company published its earnings release without the accompanying commentary needed to test them.
- U.S. insurance unit volume: undisclosed; the 10-K will show if the contraction has reached a sixth quarter.
- U.S. insurance ASP: undisclosed; crucial for testing the failed price-offset mechanism.
- Total loss frequency: no calendar Q2 figure was provided.
- ADAS and autonomous displacement: no management commentary.
- DOJ money-laundering investigation: no update on the unaccrued tail risk.
💲 Other KPIs
Rose 6.1% against revenue growth of 2.4%, running slightly ahead of the top line but stable in context.
Fell 10.8% year-over-year from $1,799.8 million in fiscal 2025, reflecting the weaker second-half earnings profile.
❓ Key Questions
Volume vs. Price Split
What were U.S. insurance unit volume and ASP growth in the quarter, and are they tracking toward the negative-to-flat scenario the model previously implied?
Facility Deleveraging
Why did U.S. operating margins deleverage so sharply, and how much of the facility operations increase is permanent versus cyclical?
DOJ Investigation Status
Has the DOJ money-laundering investigation progressed to a point where a range of possible loss can be estimated?
Non-Insurance Sizing
What are the specific dollar revenue and unit figures for the non-insurance whole-car channel?